Adan Medical Innovation was born in July 2013 between Silicon Valley and Barcelona. The idea became a reality during an Innovation program (Imagine Creativity Center) in Silicon Valley, were the co-founders Anna Sala and Adrian Curran reframed all the concerns that the patients who suffer allergic reactions have and prototyped the idea, defining the next steps. The first thing was to put together an appropriate team, with the main aim of “improving the quality of life of patients that suffer anaphylaxis”.
“If you want to go fast go alone, but if you want to go far go together “. With this in mind, Adan Medical Innovation wanted to be a different health tech company, and created a multidisciplinary team with experts in all the different areas that the project needed (clinical, regulatory, hardware&software, quality control, design…), also including patients, to be able to bring excellence to the project.
During these years, the team has grown and worked very hard, always with the purpose to improve the development of our solution. The first clinical trial with a device evaluating its usefulness for the management of anaphylaxis has been completed in one of the largest hospitals in Europe. Currently, with the improved solution and the clinical trial completed, we are working on the last steps to bring anAPPhylaxis to the market, which involve regulatory clearance. In addition, we are also working with new technologies to bring our solution to public spaces using IOT, to be able to improve the quality of life of all potential patients and increase the awareness and knowledge of the disease around the world.